Market Analysis and Price Projections for Adderall (NDC: 57844-0130)
Introduction
Adderall, a medication composed of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate, is widely used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy. Here, we will delve into the market analysis and price projections for Adderall, specifically the 30 mg immediate-release tablets (NDC: 57844-0130).
Market Trends and Drug Price Inflation
The pharmaceutical market is experiencing significant changes, particularly in terms of pricing. According to Vizient's summer 2024 Pharmacy Market Outlook, the overall drug price inflation rate for 2025 is projected to be 3.81%[2][3].
Specific Drug Price Projections
While the general inflation rate provides a broad context, specific drugs like Adderall can have varying price trajectories. Here are some key points to consider:
Historical Pricing
Adderall, being a well-established medication, has seen stable pricing over the years, but it is not immune to the broader trends in pharmaceutical pricing. The Oregon Prescription Drug Price Transparency Act highlights that many prescription drugs, including those costing over $100 a month, can experience annual price increases ranging from 10% to 20%[5].
Current Market Dynamics
The market for ADHD medications, including Adderall, is subject to various factors such as competition, regulatory changes, and supply chain disruptions. For instance, the recent shortages of amphetamine mixed salts tablets, including Adderall, have been reported due to intermittent back orders from manufacturers like Teva and Granules[4].
Supply Chain and Availability
The availability of Adderall 30 mg immediate-release tablets (NDC: 57844-0130) is currently affected by supply chain issues. Here are some key points:
Manufacturer Status
- Teva Pharmaceuticals: The company is experiencing intermittent back orders for various strengths of Adderall, including the 30 mg tablets. Supplies are being released as they become available[4].
- Other Manufacturers: Other manufacturers like Granules and Mallinckrodt also face supply constraints, with some strengths on back order or in limited supply[4].
Impact of Shortages on Pricing
Shortages can lead to price volatility. When demand exceeds supply, prices may increase due to the scarcity of the product. However, in the case of Adderall, the DEA Schedule II classification and the high potential for abuse and misuse also play a role in pricing and availability[1].
Future Price Projections
Given the current market trends and supply chain issues:
Short-Term Projections
- For 2025, the price of Adderall 30 mg immediate-release tablets may see a moderate increase, aligning with the overall drug price inflation rate of 3.81% projected by Vizient[2][3].
- The impact of supply chain disruptions could lead to temporary price spikes, but these are likely to stabilize once the supply issues are resolved.
Long-Term Projections
- In the long term, the pricing of Adderall will be influenced by broader market factors such as competition from generic versions, regulatory changes, and advancements in ADHD treatment options.
- The integration of new therapies and the expanding indications of existing medications, as seen with GLP-1 agents, could also impact the market dynamics for ADHD medications[2].
Key Takeaways
- Market Trends: The pharmaceutical market is expected to see a 3.81% price inflation rate in 2025.
- Supply Chain: Current shortages of Adderall 30 mg tablets due to intermittent back orders from manufacturers.
- Pricing: Short-term price increases likely due to supply chain issues, with long-term stability expected once supply issues are resolved.
- Regulatory and Market Factors: DEA Schedule II classification and broader market trends will continue to influence pricing and availability.
FAQs
-
What is the current status of Adderall 30 mg immediate-release tablets in terms of supply?
- Adderall 30 mg immediate-release tablets are currently on intermittent back order from manufacturers like Teva, with supplies being released as they become available[4].
-
How does the DEA Schedule II classification affect Adderall pricing?
- The DEA Schedule II classification indicates a high potential for abuse and misuse, which can impact pricing and availability due to stricter regulatory controls[1].
-
What are the projected price increases for Adderall in 2025?
- The overall drug price inflation rate for 2025 is projected to be 3.81%, which may apply to Adderall as well, though specific increases could vary based on supply chain and market dynamics[2][3].
-
How do supply chain disruptions affect the pricing of Adderall?
- Supply chain disruptions can lead to temporary price spikes due to scarcity, but prices are likely to stabilize once the supply issues are resolved[4].
-
What are the long-term factors that could influence the pricing of Adderall?
- Long-term factors include competition from generic versions, regulatory changes, and advancements in ADHD treatment options, as well as the integration of new therapies and expanding indications of existing medications[2].
Sources
- DailyMed: Adderall- dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate tablet.
- Vizient Inc.: Vizient projects drug price inflation at 3.81%.
- Vizient Inc.: Pharmacy Market Outlook Summer 2024.
- ASHP: Amphetamine Mixed Salts, Immediate-Release Tablets.
- Oregon Department of Consumer and Business Services: Prescription Drug Price Transparency Results and Recommendations.
